Shandong Fengyuan Chemical Co., Ltd. (SHE:002805)
China · Delayed Price · Currency is CNY 16.38
+0.02 (0.12%)
At close: Feb 13, 2026
SHE:002805 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,681 | 1,488 | 2,734 | 1,681 | 777.78 | 352.1 |
Other Revenue | 1.28 | 1.28 | 42.86 | 54.25 | 25.27 | 5.17 |
| 1,683 | 1,490 | 2,777 | 1,736 | 803.05 | 357.26 | |
Revenue Growth (YoY) | 17.21% | -46.35% | 59.98% | 116.14% | 124.78% | -21.99% |
Cost of Revenue | 2,036 | 1,770 | 2,999 | 1,422 | 680.86 | 343.19 |
Gross Profit | -353.74 | -280.18 | -222.16 | 314.03 | 122.19 | 14.08 |
Selling, General & Admin | 53.72 | 51.4 | 70.34 | 56.18 | 24.23 | 18.55 |
Research & Development | 73.16 | 23.73 | 29.8 | 14.64 | 9.3 | 10.18 |
Other Operating Expenses | 9.12 | 6.38 | 10.14 | 6.31 | 3.68 | 2.9 |
Operating Expenses | 128.72 | 83.21 | 104.72 | 86.76 | 48.74 | 45.04 |
Operating Income | -482.46 | -363.38 | -326.88 | 227.27 | 73.45 | -30.96 |
Interest Expense | -67.28 | -67.28 | -74.7 | -33.76 | -6.32 | -13.04 |
Interest & Investment Income | 4.49 | 4.93 | 6.17 | 6.24 | 2.79 | 0.59 |
Currency Exchange Gain (Loss) | 0.35 | 0.35 | 0.17 | 0.81 | -0.35 | -0.53 |
Other Non Operating Income (Expenses) | -42.68 | -10.49 | -76.63 | -5.97 | -0.66 | -0.63 |
EBT Excluding Unusual Items | -587.6 | -435.88 | -471.86 | 194.59 | 68.91 | -44.57 |
Gain (Loss) on Sale of Investments | - | - | 0.03 | -8.77 | -2.79 | -0.71 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | -0.02 | - | - | -0.33 |
Asset Writedown | -82.2 | -24.42 | -61.42 | - | - | - |
Other Unusual Items | -1.53 | 2.22 | 14.78 | -6.3 | 1.89 | 6.38 |
Pretax Income | -671.31 | -458.06 | -518.49 | 179.53 | 68.01 | -39.23 |
Income Tax Expense | 28.21 | -12.13 | -86.17 | 28.7 | 14.96 | -10.03 |
Earnings From Continuing Operations | -699.52 | -445.93 | -432.33 | 150.82 | 53.05 | -29.2 |
Minority Interest in Earnings | 92.36 | 83.71 | 43.01 | 0.06 | 0.04 | - |
Net Income | -607.17 | -362.23 | -389.32 | 150.88 | 53.09 | -29.2 |
Net Income to Common | -607.17 | -362.23 | -389.32 | 150.88 | 53.09 | -29.2 |
Net Income Growth | - | - | - | 184.20% | - | - |
Shares Outstanding (Basic) | 279 | 281 | 280 | 256 | 225 | 204 |
Shares Outstanding (Diluted) | 279 | 281 | 280 | 256 | 225 | 204 |
Shares Change (YoY) | -1.28% | 0.25% | 9.52% | 13.54% | 10.22% | 3.01% |
EPS (Basic) | -2.17 | -1.29 | -1.39 | 0.59 | 0.24 | -0.14 |
EPS (Diluted) | -2.17 | -1.29 | -1.39 | 0.59 | 0.24 | -0.14 |
EPS Growth | - | - | - | 150.32% | - | - |
Free Cash Flow | -179.4 | -263.76 | -1,920 | -2,511 | -305.84 | -42 |
Free Cash Flow Per Share | -0.64 | -0.94 | -6.85 | -9.82 | -1.36 | -0.21 |
Dividend Per Share | - | - | - | 0.071 | 0.021 | - |
Dividend Growth | - | - | - | 233.65% | - | - |
Gross Margin | -21.02% | -18.81% | -8.00% | 18.09% | 15.22% | 3.94% |
Operating Margin | -28.67% | -24.39% | -11.77% | 13.09% | 9.15% | -8.67% |
Profit Margin | -36.09% | -24.32% | -14.02% | 8.69% | 6.61% | -8.17% |
Free Cash Flow Margin | -10.66% | -17.71% | -69.13% | -144.64% | -38.09% | -11.76% |
EBITDA | -231.11 | -166.84 | -203.43 | 282.69 | 107.85 | 0.82 |
EBITDA Margin | -13.73% | -11.20% | -7.33% | 16.29% | 13.43% | 0.23% |
D&A For EBITDA | 251.36 | 196.54 | 123.45 | 55.42 | 34.4 | 31.78 |
EBIT | -482.46 | -363.38 | -326.88 | 227.27 | 73.45 | -30.96 |
EBIT Margin | -28.67% | -24.39% | -11.77% | 13.09% | 9.15% | -8.67% |
Effective Tax Rate | - | - | - | 15.99% | 22.00% | - |
Revenue as Reported | 1,683 | 1,490 | 2,777 | 1,736 | 803.05 | 357.26 |
Advertising Expenses | - | 0.11 | 0.05 | 0.22 | 0.07 | 0.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.